The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treatments

Publisher: Bentham Science Publishers

E-ISSN: 1875-5453|13|9|1303-1312

ISSN: 1389-2002

Source: Current Drug Metabolism, Vol.13, Iss.9, 2012-11, pp. : 1303-1312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content